[ad_1]
NEW ORLEANS, Jan. 17, 2022 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 18, 2022 to file lead plaintiff applications in a securities class action lawsuit against Reata Pharmaceuticals, Inc. (NASDAQGM:RETA), if they purchased the Company’s securities, and/or sold put options between November 9, 2020 and December 8, 2021, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of Texas.
What You May Do
If you purchased securities and/or sold put options of Reata as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to …
Full story available on Benzinga.com
[ad_2]
Source link
